LDOS · Q1 FY26 · Apr 3, 2026
Leidos Q1 FY26: where the revenue came from and where it went
Leidos Q1 FY26: revenue $4.4B (+4% year over year). Net profit $0.3B. Largest cohort Health $1.2B. The whole income statement as a sankey diagram from the SEC filing.
- Period
- Apr 3, 2026
- Reported
- May 5, 2026
Tap the diagram to enlarge · figures in billions of dollars
Revenue$4.4B
+4% year over year
Gross profit$0.8B
17% margin
Operating profit$0.5B
12% margin
Net profit$0.3B
7% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 4.4 | 100% | +4% |
| Health | 1.2 | 27% | |
| Defense | 0.9 | 20% | |
| Homeland | 0.8 | 18% | |
| Commercial and non-U.S. customers | 0.6 | 14% | |
| Time-and-materials and… | 0.6 | 14% | |
| International | 0.4 | 9% | |
| Cost of revenue | −3.6 | 82% | |
| Gross profit | 0.8 | 17% margin | −1pp |
| SG&A | −0.2 | 5% | +0pp |
| Other | −0 | 1% | +0pp |
| Operating profit | 0.5 | 12% margin | −1pp |
| Tax | −0.1 | ||
| Interest & other costs | −0.1 | ||
| Net profit | 0.3 | 7% | −1pp |
Older quarters
-
Q2 FY25 7/2025Revenue $4.3B Net margin 9%
-
Q4 FY24 1/2025Revenue $4.4B Net margin 7%
-
Q3 FY24 9/2024Revenue $4.2B Net margin 9%
New results in your inbox
When a big company reports, you get the diagram before anyone has time to comment on it. No spam, one-click unsubscribe.